0001595585-21-000018.txt : 20210115
0001595585-21-000018.hdr.sgml : 20210115
20210115163202
ACCESSION NUMBER: 0001595585-21-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210113
FILED AS OF DATE: 20210115
DATE AS OF CHANGE: 20210115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KLAERNER GERRIT
CENTRAL INDEX KEY: 0001743681
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38558
FILM NUMBER: 21532490
MAIL ADDRESS:
STREET 1: C/O TRICIDA, INC.
STREET 2: 7000 SHORELINE COURT, SUITE 201
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tricida, Inc.
CENTRAL INDEX KEY: 0001595585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463372526
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7000 SHORELINE COURT, SUITE 201
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-429-7800
MAIL ADDRESS:
STREET 1: 7000 SHORELINE COURT, SUITE 201
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
wf-form4_161074630769056.xml
FORM 4
X0306
4
2021-01-13
0
0001595585
Tricida, Inc.
TCDA
0001743681
KLAERNER GERRIT
7000 SHORELINE COURT, SUITE 201
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
Common Stock
2021-01-13
4
S
0
15035
7.41
D
509648
D
Common Stock
2021-01-14
4
S
0
1655
7.18
D
507993
D
Common Stock
25323
I
By Spouse
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.22 to $7.63, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.06 to $7.32, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The shares were awarded to the reporting person's spouse in connection with independent services provided by the spouse to Tricida, Inc.
/s/ Geoffrey M. Parker, attorney-in-fact
2021-01-15